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Background. In cost-effectiveness analysis (CEA), it is
common to compare a single, new intervention with 1 or
more existing interventions representing current practice
ignoring other, unrelated interventions. Sectoral CEAs, in
contrast, take a perspective in which the costs and effec-
tiveness of all possible interventions within a certain dis-
ease area or health care sector are compared to maximize
health in a society given resource constraints. Stochastic
league tables (SLT) have been developed to represent
uncertainty in sectoral CEAs but have 2 shortcomings: 1)
the probabilities reflect inclusion of individual interven-
tions and not strategies and 2) data on robustness are lack-
ing. The authors developed an extension of SLT that
addresses these shortcomings. Methods. Analogous to non-
probabilistic MAXIMIN decision rules, the uncertainty of
the performance of strategies in sectoral CEAs may be
judged with respect to worst possible outcomes, in terms
of health effects obtainable within a given budget.
Therefore, the authors assessed robustness of strategies
likely to be optimal by performing optimization separately
on all samples and on samples yielding worse than ex-
pected health benefits. The approach was tested on 2 ex-
amples, 1 with independent and 1 with correlated cost
and effect data. Results. The method was applicable to
the original SLT example and to a new example and pro-
vided clear and easily interpretable results. Identification
of interventions with robust performance as well as the
best performing strategies was straightforward. Further-
more, the robustness of strategies was assessed with
a MAXIMIN decision rule. Conclusion.T h eS L Te x t e n s i o n
improves the comprehensibility and extends the usefulness
of outcomes of SLT for decision makers. Its use is recom-
mended whenever an SLT approach is considered. Key
words: cost-effectiveness analysis; resource allocation;
decision analysis; uncertainty analysis. (Med Decis Mak-
ing 2012;32:477–487)
D
uring the last 3 decades, methods for handling
and presenting uncertainty in the results of
economic evaluations have been developed. Most
economic evaluations compare a limited set of spe-
cific and related interventions, for example, differ-
ent treatment modalities for a single disease.
1 For
such evaluations, the effect of uncertainty in input
parameters can be assessed with probabilistic sensi-
tivity analysis (PSA), or bootstrapping, and visual-
ized with cost-effectiveness acceptability curves
(CEAC).
2 However, if the number of interventions
under consideration increases, the interpretation of
the results of these methods becomes difficult. For
many purposes, it has been recognized that all rele-
vant interventions ideally should be evaluated
jointly to avoid methodological inconsistencies
and allow for disease dependencies as well as inter-
actions among interventions.
3,4 Such an overall
combined approach, with an explicit budget con-
straint, has been labeled ‘‘sectoral’’ or ‘‘generalized’’
cost-effectiveness analysis (CEA).
1,5–7 The broader
perspective of sectoral CEAs is based on the notion
that health care resources should be allocated across
interventions and population groups such that over-
all population health is maximized. Only by
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identify certain current interventions having unfa-
vorable cost-effectiveness and other, not yet (fully)
implemented interventions having favorable cost-
effectiveness. Such identification can trigger
resource reallocation from cost-ineffective to cost-
effective interventions, aimed at improving popula-
tion health.
1 However, despite the more complete
information provided by sectoral CEAs compared
with ordinary (single) CEAs, few of them have been
conducted.
4 One notable exception is the ACE pro-
ject, in which cost-effectiveness information was
gathered in a structured way for a range of 123 differ-
ent preventive interventions addressing noncommu-
nicable diseases. Subsequently, 27 of these were
evaluated comprehensively and compared with
each other.
8,9 For several topics, among them alco-
hol abuse, obesity, and physical inactivity, optimal
packages of interventions for the Australian popula-
tion were estimated and efficiency frontiers depicted
in a cost-effectiveness plane, showing what combina-
tions of interventions would result in most health
gains at lowest costs. Although the individual evalua-
tions included assessment of uncertainty, the results
on optimal packages were for the point estimates and
only presented information on uncertainty in a quali-
tative way. Using a somewhat different terms, other
applications evaluating a large number of interven-
tions simultaneously were called resource allocation
or budget allocation applications.
10–13 Some of these
applications considered a very wide range of inter-
ventions,
12,13 whereas most were focused on a single
disease or risk factor.
10,11
We hypothesize that 2 main reasons exist for the
lack of applications of sectoral CEA and resource allo-
cation models. First, applying sectoral CEA requires
extensive and complex information, for example, on
the interactions between interventions and targeted
diseases.
4 If decision makers are concerned with prior-
ities over broader fields of application or concerning
interventions with a large budgetary impact, however,
then gathering more information and performing a sec-
toral CEA may be worthwhile. Second, the approach
toward uncertainty in sectoral CEAs and resource allo-
cation applications may still be improved consider-
ably. Most published resource allocation models
were deterministic and did not include an uncertainty
analysis. Stochastic programming is the most straight-
forward extension of deterministic allocation models
and has been explored in several methodological pub-
lications.
14–16 However, no applications have been
published so far.
Stochastic league tables (SLTs) have been specifi-
cally developed to assess the performance of inter-
ventions in sectoral CEAs while accounting for
uncertainty in costs and effects.
17,18 The SLT con-
sists of probabilities of interventions being included
in the optimal mix of interventions for a given bud-
get, presented for a range of budgets. It has been
applied to case studies in diabetes and cardiovascu-
lar disease.
19 Alternatively, multi-intervention
CEACs can be used to visualize uncertainty.
20
These approaches, however, have certain limita-
tions. First, both the SLT and the CEAC approach
focus on interventions and report which interven-
tions may be part of an optimal strategy. However,
this information does not allow the immediate iden-
tification of the actual optimal strategies, that is, the
actual combination of interventions that is expected
to yield the best balance between health outcomes
and costs. Identification of such optimal strategies,
which is paramount for decision making, requires
extending the existing methods. Second, although
the SLT and the CEAC approach are stochastic and
account for uncertainty in the input, that is, the
costs and effects of the interventions considered,
they do not incorporate any uncertainty analysis of
the output, that is, the probability that a specific
intervention or strategy is optimal. We will illustrate
these 2 limitations in 2 examples.
This article presents an extension of the SLT
approach that provides information on the optimal
strategies as well as the optimal interventions and
incorporates a simple uncertainty analysis of the
results.
METHODS
Examples
Our extension is based on the previously pub-
lished method of stochastic league tables.
17,18 We
applied the extension to the example in the original
article by Hutubessy and others
17 as well as to a sec-
ond, new example. In these examples, mutually
exclusive sets of interventions are considered.
Mutual exclusion in health care settings may occur
when different variations of interventions, such as,
for example, screening programs, are considered, of
which at most 1 variation will be implemented.
Interventions that can always be implemented in
combination with all other interventions will consti-
tute their own set. Hence, mutual exclusivity of
interventions is not required for this analysis. Note
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not have units of measure associated with them.
Costs, resource constraints, and budgets could be
expressed in, for example, US dollars, Euros, or
any other currency. Effects could be expressed in
terms of, for example, quality or disability
adjusted life-years or some other general measure
of health.
Table 1A contains the hypothetical example first
outlined by Hutubessy and colleagues in Table 1 of
their original paper on SLTs.
17 Three mutually
exclusive sets of interventions were defined: A1-
A4, B1-B3, and C1-C4. To reflect uncertainty, log-
normal distributions were defined for the costs and
normal distributions for the effects of each of the
11 interventions. Costs and effects were assumed
to be independent for all separate interventions
and between interventions, and fixed standard devi-
ations were used for all distributions. Note, how-
ever, that the SLT method does not require these
simplifications and can also be applied when data
are dependent. The amount of different possible
strategy combinations for this situation equals 99,
as we can pick any one of or none of the interven-
tions A1-A4, any one of or none of the interventions
B1-B3, and any one of or none of the interventions
C1-C4; that is, we have 5 3 4 3 5 = 100 combinations
but ignore the one in which no intervention is
picked at all. In the remainder, combinations of
interventions will be referred to as strategies. For
each strategy, the costs and effects are defined as
the sum of the costs and effects of all individual
interventions it contains.
Table 2A contains the data for the second hypo-
thetical example. Here, 5 mutually exclusive sets of
interventions are defined: A1-A2, B1-B2, C, D1-D5,
and E1-E3. To reflect uncertainty, normal distribu-
tions were defined for the costs and for the effects
of each of these 13 interventions. Costs and effects
were correlated within interventions (r =0 . 5 0 ) ,a n d
costs as well as effects were also correlated between
interventions in the same mutually exclusive set (r
= 0.25). In this second example, the number of possi-
ble strategies equals (3 3 3 3 2 3 6 3 4) – 1= 431.
Algorithm for SLT
We reproduced the WHO-CHOICE (CHOosing
Interventions that are Cost-Effective) implementa-
tion of the SLT method, called MCLeague, in the R
software environment for statistical computing and
graphics (v2.11.1, code available on request).
21 Our
implementation was as straightforward as possible
and consisted of the following steps, for a given bud-
get X:
1. Generate all possible valid strategies, that is, all pos-
sible combinations of interventions, from the mutu-
ally exclusive sets.
2. Generate a large number of samples, for example,
25,000, of costs and effects for each separate
intervention.
3. Determine the following for each sample:
a. The total cost and total effect of each strategy by
summing up the costs and summing up the
effects of the interventions comprising the
strategy
b. The strategy that provides the largest health
effect among all strategies with a total cost less
than or equal to the given budget X. This is the
optimal strategy for that sample; record this strat-
egy and the health effect it provides in this
sample
4. Determine the following based on all samples:
a. For each strategy: how many times it was the
optimal strategy
b. For each intervention: how many times it was
contained in an optimal strategy
Here, Step 3b implements a specific optimality cri-
terion involving a tradeoff between the health effects
provided by strategies and their likelihood of not
exceeding the budget. In each sample, only strategies
that stay within budget may be optimal. Applying
a different optimality criterion may result in different
optimal strategies. However, the steps of the optimi-
zation algorithm itself remain unchanged, apart
from the selection of the optimal strategy in Step 3b.
Note that Step 4a is an addition to the original
SLT approach, resulting in information about the
optimality of strategies (combinations of interven-
tions) rather than separate interventions.
Extending SLT with Uncertainty Analysis
We also extended the stochastic league table
method with a basic form of uncertainty analysis. To
this end we applied probabilistic analogies to the non-
probabilistic MAXIMIN and MAXIMAX principles.
The MAXIMIN principle is based on evaluating each
option in terms of its worst possible outcome and
then selecting the option with the best of these worst
outcomes (maximum of the minimums). Conversely,
the MAXIMAX principle is based on evaluating each
option in terms of its best possible outcome and then
selecting the option with the best of these best out-
comes (maximum of the maximums). Hence, the
MAXIMIN principle can be viewed as a cautious, or
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ple can be viewed as an optimistic approach. To assess
uncertainty, the variation in ‘‘optimality’’ of the con-
sidered strategies can be assessed; that is, it can be
determined how robust the estimated probability for
strategies of being optimal (Step 4a) actually is.
Therefore, we extended our previous implemen-
tation to assess the variation in performance of all
selected strategies (i.e., those with .5% chance of
being optimal as determined in Step 4a) by modify-
ing Step 2 to generate more samples (i.e., 100,000)
and adding Step 5, defined as follows:
5. Determine the following for each (selected) strategy:
a. The subset of samples in which this strategy pro-
vides relatively small health effects (defined
below)
b. The probability that this strategy was the optimal
strategy in the subset of 5a
c. The subset of samples in which this strategy pro-
vides relatively large health effects (defined
below)
d. The probability that this strategy was the optimal
strategy in the subset of 5c
In this Step 5, the performance of each strategy is
assessed based on conditional sampling. For each
strategy we independently defined samples with rel-
atively small health effects (Step 5a) as all samples
with health effects below the 25th percentile of the
distribution of health effects for that strategy. Sam-
ples with large health effects (Step 5c) were defined
as samples in which the health effects exceeded the
75th percentile of the corresponding distribution for
Table 1A Costs and Effects of 3 Independent Sets of Mutually Exclusive Interventions in Example 1, First
Proposed by Hutubessy and Colleagues
17
Intervention
Total Costs Total Effects
 x s  x s
A1 120 20 1 2
A2 140 20 5.5 2
A3 170 20 3 2
A4 190 20 7 2
B1 100 20 12 2
B2 120 20 17 2
B3 150 20 20 2
C1 50 20 22 2
C2 70 20 24.5 2
C3 120 20 29 2
C4 170 20 31 2
Table 1B Corresponding Stochastic League Table (SLT) Based on Our Implementation
Intervention
Resource Availability
50 100 150 200 300 400 600 800
A 1 00002810
A2 0 0 0 0 9 47 28 28
A 3 00000444
A4 0 0 0 0 1 21 67 67
B1 0 2 37 15 3 3 0 0
B2 0 0 24 45 33 32 15 15
B 3 0 0 24 06 46 48 58 5
C1 51 22 43 36 5 5 0 0
C2 13 63 24 49 10 18 0 0
C 3 01 42 71 44 94 72 42 4
C4 0 0 5 1 35 31 76 76
Note: The SLT presents the probability of inclusion (%) of the intervention in the optimal strategy at different budget levels
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the performance of strategies for situations in which
they provide either (much) more or less health
effects than expected, independent of the health
effects provided by other strategies. Steps 5a and
5b, evaluating only samples with the worst 25%
health effects per strategy, may be seen as a probabi-
listic equivalent of the nonprobabilistic MAXIMIN
principle. Conversely, Steps 5c and 5d may be
viewed as a probabilistic equivalent of the MAXI-
MAX principle. The larger number of samples gener-
ated in Step 2 (100,000 instead of 25,000) is required
to again obtain 25,000 samples after conditioning on
a selection of 25% of all generated samples in Step
5. Note that because of conditional sampling, the
sample base (subset of samples) corresponding to
each strategy will be different.
RESULTS
The standard presentation of the results of an SLT
is a table showing the probability of inclusion of
each intervention in the optimal strategy given cer-
tain levels of resource availability (Step 4b from
the algorithm). Table 1B represents the results of
our SLT implementation for the first example
(defined in Table 1A), based on 100,000 samples.
Table 2B represents the results of our SLT imple-
mentation for example 2 (defined in Table 2A),
also based on 100,000 samples. A rerun with the
same number of samples provided identical results
for Tables 1B and 2B, indicating that sufficient sam-
ples were generated to yield robust results. Here, the
SLTs in Tables 1B and 2B clearly illustrate the 2 lim-
itations mentioned in the introduction: 1) They do
not provide any explicit information on the optimal-
ity of strategies, and 2) they do not incorporate any
uncertainty analysis of the output. For instance, for
a budget of 400 in the first example (Table 1B), inter-
ventions A2, A4, B2, B3, C3 and C4 all look promis-
ing, but which combinations of these interventions
actually make up promising strategies cannot be
determined. Furthermore, the robustness of the
probabilities of optimality for these interventions
is not clear. When interventions perform better (or
worse) than expected, this may affect their proba-
bility of being optimal to a different extent. That
is, some interventions always show a high probabil-
ity of being optimal, whereas others have large var-
iability in their outcomes and thus may be
excluded from the optimal set if they perform
worse than expected. Estimating this variation,
due to better (or worse) than expected performance,
which is not shown in the standard SLT, allows
assessment of the robustness of the SLT results.
For example, in Table 1B, if the probability for C3
with point estimate 47% could actually range
from 20% (if C3 performs very poorly) to 80% (if
C3 performs very well) and if for C4, with point
estimate 31%, this range could be 10% to 60%,
we would be less certain that C3 is better than C4
than when these respective ranges could be 40%
to 55% and 20% to 42%.
Table 1C Optimality of Strategies and Interventions for Example 1 and a Fixed Budget of 300
Probability of
Being Optimal
Cumulative
Probability
of Optimality
Probability of Intervention Being Optimal Due
to Incorporation in Best Strategy 1–4
Best Strategies A1 A2 A3 A4 B1 B2 B3 C1 C2 C3 C4
1 Interventions B3-C3 41% 41% — — — — — — 41% — — 41% —
2 Interventions B2-C4 18% 59% — — — — — 18% — — — — 18%
3 Interventions B3-C4 15% 74% — — — — — — 15% — — — 15%
4 Interventions B2-C3 8% 82% — — — — — 8% — — — 8% —
82% 0% 0% 0% 0% 0% 26% 56% 0% 0% 49% 33%
Probability of Intervention Being Optimal
Due to Incorporation in Any Remaining Strategy
A1 A2 A3 A4 B1 B2 B3 C1 C2 C3 C4
All remaining strategies 18% 100% 2% 9% 0% 1% 3% 7% 8% 5% 10% 0% 2%
Total probability
of intervention
being optimal
2% 9% 0% 1% 3% 33% 64% 5% 10% 49% 35%
Note: Interventions not included in the best strategies are indicated by dashes.
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From our algorithm we additionally determined
the probability that strategies are optimal (Step 4a
from the algorithm). Table 1C shows the results of
the algorithm for the first example (defined in Table
1A) and a fixed budget of 300. Similarly, Table 2C
shows the results corresponding to the second exam-
ple (defined in Table 2A) and a fixed budget of 100
(31,000,000). In Tables 1C and 2C, all strategies are
shown that have a probability of being optimal of at
least 5%. This 5% threshold was set to make sure
that only strategies that definitely would not interest
decision makers are dropped. In practice, decision
makers will have their own (implicit) threshold
above which strategies may be deemed eligible for
implementation, and our 5% can be seen as the low-
est imaginable threshold resulting in a table with all
possibly relevant strategies. In Table 1C, the result-
ing 4 ‘‘best’’ strategies are B3-C3, B2-C4, B3-C4,
and B2-C3 and have a respective probability of being
optimal of 41%, 18%, 15%, and 8%. Combined,
these strategies have a 41% 1 18% 1 15% 1 8% =
82% probability of being optimal, indicating that
the 99 – 4 = 95 remaining strategies have a combined
probability of 100% – 82% = 18% of being optimal.
Table 2A Costs and Effects of 5 Independent Sets of Mutually Exclusive Interventions for Example 2
Intervention
Total Costs (31000) Total Effects
 x s  x s
A1 212,000 84,853 9700 1162
A2 46,800 20,000 6000 721
B1 174,000 69,282 29,000 3479
B2 18,300 10,000 26,000 3114
C 127,000 50,990 57,000 6841
D1 37,000 17,321 19,000 1500
D2 268,000 14,142 21,000 7099
D3 95,000 112,250 40,000 1500
D4 385,000 85,440 50,000 1800
D5 307,000 102,470 57,000 5604
E1 750,000 300,000 52,000 6237
E2 336,000 134,536 51,000 6124
E3 1000 400 38,000 4561
Note: Here, costs and effects are correlated within interventions (r = 0.50), and costs as well as effects are correlated between interventions in the same
mutually exclusive set (r = 0.25).
Table 2B Corresponding Stochastic League Table (SLT) Based on Our Implementation
Intervention
Resource Availability (31,000,000)
50 100 200 300 400 600 800 1000
A1 5 6 11 18 20 25 42 53
A2 53 44 64 60 57 61 50 41
B 1 33 71 41 62 13 64 4
B2 85 85 92 86 84 79 64 56
C 44 78 100 100 100 100 100 100
D 1 1 2572000
D2 78 76 58 26 10 1 0 0
D3 21 22 35 58 56 15 7 2
D 4 0 0002545
D5 0 0 1 9 29 79 90 93
E 1 1 1122246
E2 2 2 4 8 13 21 47 76
E3 97 97 95 90 85 77 50 18
Note: The SLT presents the probability of inclusion (%) of the intervention in the optimal strategy at different budget levels.
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an intervention is part of 1 of the 4 best strategies
and the probability that it is part of the remaining
strategies. For example, intervention A1 is not con-
tained in any of the 4 best strategies but is contained
in 2% of all optimal strategies. Intervention B3,
however, is contained in best strategies 1 and 3,
which have a probability of being optimal of 41%
and 15%, as well as in 8% of the optimal remaining
strategies. Therefore, intervention B3 has a probabil-
ity of 41% 1 15% 1 8% = 64% of being included in
an optimal intervention. In Table 2C, 6 ‘‘best’’ strat-
egies are shown with a combined probability of
being optimal of 73%. Results in Table 2C can be
interpreted similarly to results shown in Table 1C,
even though in this second example costs and
effects were correlated instead of independent.
Note that in Tables 1C and 2C we distinguish
between the optimality of strategies and the optimal-
ity of single interventions.
Extending SLT with Robustness Analysis
Figure 1 shows an example of the selection of
samples in the additional step—Step 5. In Figure
1, the distribution of health effects is shown for 2
example strategies: A1-B2-D3 and A2-D2-E2. In
addition, the distribution of the conditional samples
corresponding to the 25% worst and 25% best
health effects for these strategies is shown. Here,
the expected costs (not visualized) and effects are
325,300 and 75,700 for strategy A1-B2-D3 and
314,800 and 78,000 for strategy A2-D2-E2, respec-
tively. Hence, strategy A2-D2-E2 would be preferred
over strategy A1-B2-D3, when only expected costs
and effects are considered, as it is expected to be
cheaper and more effective. However, from Figure
1 it is apparent that the health effects provided by
strategy A1-B2-D3 are more certain (i.e., display
less variation) than the health effects provided by
strategy A2-D2-E2. As a result, the expected health
benefits in the worst 25% samples of strategy A1-
B2-D3 are larger than those expected for in the worst
25% samples of strategy A2-D2-E2. This indicates
that strategy A1-B2-D3 is more robust than strategy
A2-D2-E2 and indeed would be preferred when
applying a MAXIMIN decision rule. Conversely,
the latter strategy would be preferred in a MAXIMAX
decision rule (best 25% samples), where it is
expected to provide more health effects than the for-
mer strategy.
Table 3A presents the results from reassessing the
first example (defined in Table 1A) for 3 predefined
budget values: 50, 400, and 800. Similarly, Table 3B
shows results for the second example (defined in
Table 2A) and budget values of 50, 200, and 600
(31,000,000). For these (arbitrarily) selected budget
values, Tables 3A and 3B indicate which strategies
have an estimated probability of being optimal of
at least 5%. Furthermore, the robustness of these
strategies is indicated, with a worst and best proba-
bility of optimality, respectively corresponding to
Table 2C Optimality of Strategies and Interventions for Example 2 and a Fixed Budget of 100 (31,000,000)
Best Strategies
Probability
of Being
Optimal
Cumulative
Probability
of Optimality
Probability of Intervention Being Optimal Due
to Incorporation in Best Strategy 1–4
A1 A2 B1 B2 C D1 D2 D3 D4 D5 E1 E2 E3
1 Interventions B2-C-D2-E3 28% 28% — — — 28% 28% — 28% — — — — — 28%
2 Interventions A2-B2-C-D2-E3 22% 50% — 22% — 22% 22% — 22% — — — — — 22%
3 Interventions C-D2-E3 10% 60% ———— 1 0 % — 1 0 % —— — — — 1 0 %
4 Interventions A2-B2-D2-E3 7% 67% — 7% — 7% — 7% — — — — 7%
5 Interventions B2-C-D3-E3 6% 73% — — 6% 6% — 6% — — — — 6%
6 Interventions A2-B2-C-D3-E3 5% 78% — 5% — 5% 5% — — 5% — — — — 5%
78% 0% 34% 0% 68% 71% 0% 67% 11% 0% 0% 0% 0% 78%
Probability of Intervention Being Optimal Due
to Incorporation in Any Remaining Strategy
A1 A2 B1 B2 C D1 D2 D3 D4 D5 E1 E2 E3
All remaining strategies 22% 100% 6% 10% 3% 17% 7% 2% 9% 11% 0% 0% 1% 2% 19%
Total probability
of intervention being optimal
6% 44% 3% 85% 78% 2% 76% 22% 0% 0% 1% 2% 97%
Note: Interventions not included in the best strategies are indicated by dashes.
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and best health effects for each strategy.
Table 3A shows that in our first example, for a bud-
get of 50 the strategy ‘‘only C1’’ is optimal and for
a budget of 800 the strategy A4-B3-C4 is optimal. For
a budget of 400, no single strategy has a probability
of being optimal that exceeds 20%. In general, high
probabilities of being optimal will only occur in situa-
tions where the options are limited, that is, when the
budget is either very low, and few strategies can be
afforded, or very high, and only the health effects
determine the optimality of strategies.
For budgets of 50 and 800 in this first example,
cautious or optimistic decision makers would be
likely to reach the same conclusion as neutral deci-
sion makers. For these budget values, the optimal
strategies seem to be quite robust for either best-
case or worst-case scenarios. However, for a budget
of 400, strategy B3-C4 has a slightly lower probabil-
ity of being optimal than strategy A2-B3-C3 when
mean values are considered but a slightly higher
probability of being optimal when a best-case sce-
nario is considered. None of the strategies performs
very well in the worst-case scenario.
From Table 3B it is clear that for none of the
selected budgets of 50, 200, and 600 (31,000,000)
does there exist a strategy with probability of being
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Figure 1 Distribution of health effects for 2 strategies, A1-B2-D3
and A2-D2-E2, that are part of Example 2, as defined in Table 2A.
For both strategies, the unconditional distribution of health
effects is visualized as well as the conditional distribution of
both the 25% samples with worst and the 25% samples with
best health effects. Here the expected effects are 75,700 for strat-
egy A1-B2-D3 and 78,000 for strategy A2-D2-E2, respectively. The
conditional worst/best expectations are 71,080/80,340 for strategy
A1-B2-D3 and 66,080/90,000 for strategy A2-D2-E2.
Table 3A Results of the Uncertainty Analysis for
Example 1 Defined in Table 1A, for Budget Values of
50, 400, and 800
Budget Strategy
a x Worst
a Best
a
50 C1 51 49 54
C2 13 10 14
Total selected 64
400 A2-B3-C3 19 6 32
B3-C4 15 2 34
A2-B2-C3 11 1 27
A2-B2-C4 6 1 12
A2-B3-C2 6 0 18
Total selected 57
800 A4-B3-C4 44 15 73
A2-B3-C4 18 3 40
A4-B3-C3 14 2 32
A4-B2-C4 7 0 20
A2-B3-C3 6 0 16
Total selected 89
Table 3B Results of the Uncertainty Analysis for
Example 2 Defined in Table 2A, for Budget Values of
50, 200, and 600 (3 1,000,000)
Budget (31,000,000) Strategy
a x Worst
a Best
a
50 A2-B2-D2-E3 33 27 38
B2-C-D2-E3 17 26 9
C-D2-E3 10 11 8
A2-B2-C-D2-E3 7 14 2
B2-D3-E3 6 7 5
A2-B2-D3-E3 6 8 5
Total selected 79
200 A2-B2-C-D2-E3 36 25 43
A2-B2-C-D3-E3 17 22 11
B2-C-D3-E3 12 13 10
B2-C-D2-E3 7 2 13
A1-B2-C-D2-E3 6 6 5
Total selected 78
600 A2-B2-C-D5-E3 32 22 38
A1-B2-C-D5-E3 14 15 11
A2-B1-C-D5-E3 10 11 7
A2-B2-C-D3-E2 7 3 13
A2-B2-C-D5-E2 5 9 1
Total selected 68
a. Worst performance is based on the probability of being optimal in the
25% samples providing the worst health benefits per strategy, indepen-
dent of other strategies. Best performance is based on the probability of
being optimal in the 25% of the samples providing the best health ben-
efits per strategy, independent of other strategies. Due to conditional
sampling, the sum of the probabilities of being optimal may exceed
100% in the Worst and Best performance columns.
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(mean) and 43% in the best-case scenario. Here the
effect of correlation between costs and effects, within
and between interventions, becomes apparent. For
example, for a budget of 50 (31,000,000), strategy
B2-C-D2-E3 has expected probability of being optimal
of 17%, which increases to 26% in the worst-case sce-
nario and decreases to 9% in the best-case scenario.
Conversely, for strategy A2-B2-D2-E3 and the same
budget, this probability changes from 33% to 27%
(worst case) and to 38% (best case). This difference
stems from the fact that for all strategies, the probabil-
ity of being optimal is limited by a combination of the
health effects provided and the costs incurred. When
the health effects of a strategy are relatively low,
then the probability of optimality will decrease further
when a worst-case scenario (with respect to health
effects) is considered, and costs do not play any role.
However, when the health effects of a strategy are rel-
atively high, then the probability of optimality will
largely depend on the chance to stay within budget.
Given the positive correlation of 0.5 for costs and
effects within interventions, considering worst-case
scenarios with respect to health effects will result in
the selection of samples with relatively low costs.
Hence, strategies will have lower costs than expected,
resulting in increased performance for expensive strat-
egies with large health effects and decreased perfor-
mance for (cheap) strategies with limited health
effects. Indeed, for the strategies B2-C-D2-E3 and A2-
B2-D2-E3, we find respective probabilities of 98%
and 2% of exceeding the 50 (31,000,000) budget and
health effects of 149,200 (95% confidence interval
131,582–166,895) and 90,990 (95% confidence inter-
val 73,259–108,703). Obviously, the first strategy can
only be optimal when it is less expensive than
expected, whereas the latter can only be optimal if it
results in more health effects than expected.
To assess the effect of evaluating a subset with
25% of the best and worst samples per strategy, we
repeated the analyses presented in Tables 3A and
3B with subsets of 10% and 50% of the best and
worst samples. We found that the probability of opti-
mality in worst- and best-case scenarios did not
change for the vast majority of strategies. For a few
strategies these probabilities increased or decreased
with 1% to 4%, with larger changes occurring only
for strategies with larger mean probabilities (data
not shown). However, the observed changes did
not actually influence the selection of strategies
with a probability of optimality exceeding the 5%
threshold or their ranking as presented in Tables
3A and 3B.
DISCUSSION
In this article we present an extension to the SLT
approach that enables uncertainty analysis. More-
over, we aim to communicate the information of
most interest to decision makers, that is, which par-
ticular strategies out of all possible strategies have
a high probability of being optimal. These strategies
can be considered most promising, recognizing that
their actual costs and health effects are still uncer-
tain. The implementation of our extension is
straightforward and the corresponding results are
easy to interpret. We feel that the addition of the
uncertainty analysis is valuable, as the existing
SLT approach does not explicate the overall varia-
tion in the health effects provided by interventions
and strategies.
Limitations of Our Extension
With the current unoptimized implementation it
may become infeasible to perform the proposed
analysis when the total number of interventions con-
sidered becomes too large, as would also be the case
with the standard SLT approach. When testing, we
have considered up to 20 interventions and up to
20,000 strategies without running into computa-
tional problems, although time requirements
increased from a few minutes to a few hours. Com-
putational optimization may be applied so that
larger sets of interventions or more strategies can
be assessed. However, one may wonder whether
analyses of very large sets of unrelated interventions
are attractive, especially given their information
requirements. In practice, a simultaneous analysis
of the performance of all interventions aimed at
a specific disease, for example, diabetes, is both fea-
sible and most likely to be relevant.
Ultimately, the cost-effectiveness of interventions
and of strategies is only a single aspect to be consid-
ered in priority setting in health care. Therefore,
small differences between strategies are unlikely to
have actual consequences for decision making, and
the main benefit of the proposed approach is identi-
fication of strategies that have at least a nonnegligible
probability of being optimal. This relevance check
was implemented by the probability threshold of
5% we applied in the plots and tables. When even
the highest probabilities of being optimal are rather
low, decision makers could ask for a value of infor-
mation analysis prior to selecting a strategy, to see
whether postponing the decision and collecting
additional data would be worthwhile.
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posed extension can be directly applied to both
independent and correlated cost and effect data.
Depending on costs and effects of strategies, correla-
tion between costs and effects both within and
between interventions may have substantial effect
on the resulting probabilities of optimality.
For our uncertainty analysis we defined different
hypothetical situations with respect to the health
effects provided by the optimal strategy, for a given
budget. Alternatively, we could have defined hypo-
thetical situations based on the cost incurred by the
optimal strategy, or the incremental cost-effective-
ness ratio (ICER) of the optimal strategy. To keep
in line with the original SLT approach, we assumed
a fixed budget. Therefore, conditioning on health
effects is rather intuitive, as in practice we are
uncertain about the health effects that can actually
be obtained within that budget. Finally, we defined
different hypothetical situations in which interven-
tions yield lower or higher health effects than
expected. The size of the subset (25% of the worst
or best samples) was chosen arbitrarily. Investiga-
tion of other sizes of this subset (10%, and 50%)
indicated that our results and conclusions were
robust with respect to subset size. This limited effect
of subset size in our examples may be partially due
to the normal distributions that were assumed for
effects in both examples and also for costs in the sec-
ond example. When less regular and smooth distri-
butions are used for costs and effects, the influence
of the size of the considered subset of samples may
be larger.
Comments on the SLT Approach
After the introduction of the SLT approach, some
discussions have taken place on both technical and
methodological aspects of the approach.
22–25 In par-
ticular, our extension is not intended to address the
initial objections to the SLT approach, warranted or
not, that its use could lead to potential inefficiencies
through 1) the dependence of the probabilities of
inclusion on decisions related to other programs
and 2) the failure to consider the opportunity costs
of obtaining increased health benefits.
24,25 Rather,
our extension was developed to improve the useful-
ness of results obtained with the SLT approach, for
researchers preferring this approach. From previous
discussions it can be concluded that few alternative
approaches, such as confidence or credible intervals
for the net benefit of strategies, described by Groot
Koerkamp and others
26 and Fenwick and Briggs,
27
and the incremental benefit curve, described by
Bala and others,
28 are available in addition to the
SLT approach. However, it seems that neither the
SLT approach nor any of its alternatives offer the sin-
gle best solution to analyzing uncertainty in sectoral
economic evaluations. Rather, any approach has its
advantages and disadvantages. For the SLT approach,
the most notable advantage is that it starts from a bud-
get constraint, which may be the most relevant aspect
of decision making from a policy perspective. How-
ever, this may also be seen as a disadvantage, since
the implied risk attitude toward costs is quite high.
Alternative approaches have more explicitly formu-
lated the tradeoff between money and health benefits
and the risk attitude toward uncertain outcomes on
one or both of these.
14 These, however, may lack
practical applicability since they require decision
makers to be able to formulate an explicit objective
function over risky outcomes. This complicates the
comparison between results from these different
types of analyses.
CONCLUSION
In settings in which sectoral CEA can be applied,
care should be taken to present results from the anal-
ysis as clearly and succinctly as possible to decision
makers in order to improve the usefulness of such
results. Uncertainty analysis of the results also
adds to that usefulness by providing decision mak-
ers with the opportunity to assess the robustness of
performance for strategies. Therefore, we recom-
mend the use of our extension whenever an SLT
approach is considered by health economists con-
ducting sectoral CEAs.
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